TON - December 2012, Vol 5, No 11

TON - December 2012, Vol 5, No 11 — December 20, 2012
The Johns Hopkins Kimmel Cancer Center, located on the campus of Sibley Memorial Hospital, provides medical oncology services to cancer patients in the Washington, DC, community. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
The American Society for Radiation Oncology (ASTRO) 54th Annual Meeting, held in Boston, Massachusetts, coincided with Superstorm Sandy. Despite the havoc wreaked by the storm, Boston was largely spared, although ASTRO canceled Monday afternoon’s Plenary Session when public transportation was shut down. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
Genetics as it pertains to cancer risk tends to be a hot topic in the news lately. Patients may see a story that states, for example, “Researchers have found that the risk of developing cancer in women with a mutation in gene Q is 500% higher,” but what does that risk actually mean? Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
As healthcare professionals who work with people living with cancer, we often see patients when they are most vulnerable. For many patients, their moments of greatest vulnerability are at the time of diagnosis and while discussing treatment. During such moments, patients typically feel overwhelmed and inundated with a large amount of information to process and assimilate, while at the same time dealing with the emotional impact of a cancer diagnosis. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
This issue of The Oncology Nurse-APN/PA (TON) brings you highlights of the news from the 2012 American Society for Radiation Oncology (ASTRO) annual meeting. Part of our ASTRO coverage includes the results of a study that show that many patients with incurable lung cancer misunderstood the goals of palliative radiation therapy. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
For preventing bone metastases in women with early breast cancer, the current body of evidence does not support the use of osteoclast-targeting agents, ie, bisphosphonates, according to Julie Gralow, MD, director of Breast Medical Oncology at the Fred Hutchinson Cancer Research Center in Seattle, Washington. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
The management of relapsed/ refractory acute lymphoblastic leukemia (ALL) is a vexing problem and requires extensive, aggressive supportive care throughout the course of therapy, explained Joseph C. Alvarnas, MD, City of Hope Comp­rehensive Cancer Center, Duarte, Cali­fornia, in a presentation at the National Com­prehensive Cancer Network (NCCN) 7th Annual Congress on Hematologic Malignancies. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
Sildenafil is often used by men treated with radiation or radical prostatectomy for prostate cancer to achieve an erection sufficient for sexual intercourse, and it is effective to varying degrees when used on an as-needed basis. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
Doxepin, a tricyclic antidepressant approved for the treatment of depression and anxiety, as well as moderate pruritus, significantly improved oral mucositis pain in patients treated with radiation therapy for head and neck cancer in a phase 3 trial. Read More ›

TON - December 2012, Vol 5, No 11 — December 20, 2012
Radiation therapy extends life in older women with early breast cancer, according to 2 different studies presented at the ASTRO 54th Annual Meeting. Read More ›

Page 1 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: